Virtu KCG Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History

Virtu KCG Holdings’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-11,100	Closed	-$6.03M	–	3505
2015 Q4	$6.03M	Sell	11,100 -4,300	-28%	-$2.33M	0.1%	108
2015 Q3	$7.16M	Buy	15,400 +14,300	+1,300%	+$7.68M	0.12%	91
2015 Q2	$561K	Sell	1,100 -1,600	-59%	-$781K	0.01%	1385
2015 Q1	$1.22M	Sell	2,700 -4,500	-63%	-$1.91M	0.02%	633
2014 Q4	$2.95M	Sell	7,200 -500	-6%	-$197K	0.05%	278
2014 Q3	$2.78M	Sell	7,700 -4,900	-39%	-$1.64M	0.05%	302
2014 Q2	$3.56M	Sell	12,600 -4,000	-24%	-$1.19M	0.06%	269
2014 Q1	$4.99M	Sell	16,600 -12,100	-42%	-$3.73M	0.06%	260
2013 Q4	$7.9M	Buy	28,700 +6,700	+30%	+$1.93M	0.09%	124
2013 Q3	$6.88M	Buy	+22,000	New	+$5.79M	0.09%	150

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Virtu KCG Holdings's REGN Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2017: 420 shares worth $206K. The stake represents 0.01% of the portfolio and ranks #2138 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in REGN as recently as Q4 2016.

Virtu KCG Holdings first reported a position in REGN in Q3 2013 and has held it in 14 quarters since. The position peaked at $4.88M in Q1 2014. 604 funds tracked by Wall St. Rank hold REGN as of Q2 2017.

Virtu KCG Holdings held 420 shares of Regeneron Pharmaceuticals worth $206K as of Q2 2017.
Regeneron Pharmaceuticals was a new Virtu KCG Holdings position in Q2 2017.
Regeneron Pharmaceuticals made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2138 holding.
Virtu KCG Holdings first reported a position in Regeneron Pharmaceuticals in Q3 2013 and has held it in 14 quarters since.
Virtu KCG Holdings's Regeneron Pharmaceuticals position peaked at $4.88M in Q1 2014.
604 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.